(Q41601147)

4 October 2017

1 reference

title

Epstein-Barr virus genes and cancer cells (English)

1 reference

4 October 2017

0 references

1

1 reference

4 October 2017

Cludts I

2

1 reference

PubMed ID

9309246

4 October 2017

Stühler A

series ordinal

3

1 reference

4 October 2017

1 January 1997

1 reference

Biomedicine and Pharmacotherapy

4 October 2017

1 reference

4 October 2017

51

1 reference

4 October 2017

258-267

1 reference

4 October 2017

6-7

1 reference

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus immortalizing genes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus-driven gene therapy for EBV-related lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Binding and suppression of the Myc transcriptional activation domain by p107.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus in Hodgkin's disease patients in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Viruses and human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983541-X

7 January 2021

10.1016/S0753-3322(97)83541-X

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9309246